|
Translating a clinical trial to daily practice: Outcome of palliative treatment in patients with advanced cholangiocarcinoma and gallbladder cancer in the Netherlands. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Merck; Nordic Group; Roche; SERVIER |
| |
|
Consulting or Advisory Role - Bristol-Myers Squibb; Roche/Genentech |
Travel, Accommodations, Expenses - Celgene; Sanofi |
| |
|
Consulting or Advisory Role - Ipsen; Pfizer |
| |
|
Consulting or Advisory Role - Amgen; Gilead Sciences; Roche Pharma AG |
| |
|
|
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer; Roche/Genentech |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |